COMMUNIQUÉ DE PRESSE
News
-
-
COMMUNIQUÉ DE PRESSE
Communiqué de presse : Le venglustat de Sanofi a reçu la désignation de thérapie innovante aux États-Unis pour la maladie de Gaucher de type 3
Sanofi's venglustat receives innovative therapy designation in the US for Gaucher disease type 3. Positive results from the LEAP2MONO study reinforce its potential as a treatment option -
COMMUNIQUÉ DE PRESSE
Heidelberg Pharma to Receive Milestone Payment from Partner Huadong for Clinical Study with HDP-101 in China
Heidelberg Pharma to receive milestone payment from partner Huadong for clinical study with HDP-101 in China. First patient dosed in Phase I study evaluating safety, tolerability, and efficacy -
COMMUNIQUÉ DE PRESSE
SMG reports strong 2025 results with significant margin uplift
SMG Swiss Marketplace Group reports strong 2025 financial results with revenue of CHF 332.0 million and Adjusted EBITDA up to CHF 180.2 million, lifting margin to 54.3%. Continues innovating with AI for user experience and efficiency -
-
COMMUNIQUÉ DE PRESSE
The 2025 annual results reflect developments in the companies and investments under the umbrella of TX Group AG
TX Group AG's 2025 annual results show positive developments in marketplace activities and media companies' transformation. Revenue slightly down, operational income stable -
-
COMMUNIQUÉ DE PRESSE
Zeus North America Mining Corp. Announces Upsizing and Closing of Final Tranche of Private Placement
Zeus North America Mining Corp. upsizes and closes final tranche of non-brokered private placement, raising $403,500. Insider participation noted. Funds to be used for exploration programs -
-
COMMUNIQUÉ DE PRESSE
Core Critical Metals Corp. Announces Non-Brokered LIFE Offering and Concurrent Private Placement
Core Critical Metals Corp. announces non-brokered private placement offering of up to $1.5M and concurrent private placement for general corporate purposes and exploration. Offering document available on SEDAR
